Dr Clare Verill has been appointed as CM-Path Workstream 4 Lead. Clare is a urological pathology consultant, having achieved her…
Interview with Dr Jervoise Andreyev, member of NCRI LWBC Group
'Dr Jervoise Andreyev is a steering group member for the James Lind Alliance Priority Setting Partnership within our Living With and…
CM-Path Hosts Workshop “Current and Future Challenges for Innovative Biomarker Development”
'The CM-Path workshop ‘Current and Future Challenges for Innovative Biomarker Development’ was organised by Dr Maggie Cheang and held on…
New NCRI Living With and Beyond Cancer initiative
'NCRI has formally launched its new initiative on living with and beyond cancer research on 25 April 2017. Working with…
Interview with Vee Mapunde, Associate Consumer Lead
'Vee Mapunde is Associate Consumer Lead at the NCRI. In our latest 60 second interview, Vee tells us about her role at the NCRI, and how consumer involvement adds value.…
CM-Path Consumer Spends a Day in the Glasgow Diagnostic Pathology Lab
'CM-Path members Dr Jane Hair (Discovery Workstream), Dr Hayley Morris (Skills and Capacity Workstream Trainee), Dr Tomoko Iwata (Skills and…
CM-Path Recognises the Need for Quality Assurance in Clinical Trials
'Dr Clare Verrill organised a meeting on the 21st March 2017 attended by CM-Path members, as well as representatives from…
CM-Path and RCPath Host “A Pathologist’s Guide to Research and Clinical Trials”
'On December 9th 2016, CM-Path and the Royal College of Pathologists hosted a joint workshop aimed at pathologists that want…
Gold nanoparticles help deliver lethal one-two punch to cancer
'Tagging gold nanoparticles with a small dose of radiation has helped researchers trace the precious metal as it delivers a…
Gut microbes linked to immunotherapy response in melanoma patients
'Patients with malignant melanoma – whose disease has spread – are more likely to respond to immunotherapy treatment if they…
Understanding cancer worries could break down barriers to seeking help
'Recognising the reasons people worry about a potential cancer diagnosis could help ease concern and encourage people with possible cancer…
CM-Path Hosts Industry Engagement Day
'On October 5th 2016, CM-Path invited industry representatives from pharmaceutical, molecular diagnostic and digital pathology companies to attend a workshop…